List of MedImmune, LLC patents

List of MedImmune, LLC patents

List of SRI International patents

List of Mott's patents

List of Tut Systems patents

List of companies in ACME Capital's investment portfolio

List of SBIR/STTR awards granted to BEAMTEK, INC.

Patents where

Current Assignee

Name

is

MedImmune, LLC

	Name	Description	Patent Applicant	Current Assignee	Inventor	Patent Jurisdiction	Patent Number	Date of Patent
	‌ US Patent 11279759 Bispecific binding proteins and uses thereof	Patent 11279759 was granted and assigned to MedImmune, LLC on March, 2022 by the United States Patent and Trademark Office.	MedImmune	MedImmune, LLC		United States Patent and Trademark Office	11279759	March 22, 2022
	‌ US Patent 11446377 Anti-B7-H1 and anti-CTLA-4 antibodies for treating non-small cell lung cancer		MedImmune	MedImmune, LLC		United States Patent and Trademark Office	11446377	September 20, 2022
	‌ US Patent 9308257 Protein formulation	Patent 9308257 was granted and assigned to MedImmune, LLC on April, 2016 by the United States Patent and Trademark Office.		MedImmune, LLC		United States Patent and Trademark Office	9308257	April 12, 2016
	‌ US Patent 7550149 Attenuation of cytomegalovirus virulence	Patent 7550149 was granted and assigned to MedImmune, LLC on June, 2009 by the United States Patent and Trademark Office.		MedImmune, LLC		United States Patent and Trademark Office	7550149	June 23, 2009
	‌ US Patent 8664363 Humanized anti-CD22 antibodies and their use in treatment of oncology, transplantation and autoimmune disease	Patent 8664363 was granted and assigned to MedImmune, LLC on March, 2014 by the United States Patent and Trademark Office.	MedImmune	MedImmune, LLC		United States Patent and Trademark Office	8664363	March 4, 2014
	‌ US Patent 8663636 Method of treating a malignant tumor by administering antibodies directed to DLL4	Patent 8663636 was granted and assigned to MedImmune, LLC on March, 2014 by the United States Patent and Trademark Office.		MedImmune, LLC		United States Patent and Trademark Office	8663636	March 4, 2014
	‌ US Patent 11098289 Uricase sequences and methods of treatment	Patent 11098289 was granted and assigned to MedImmune, LLC on August, 2021 by the United States Patent and Trademark Office.	MedImmune, LLC	MedImmune, LLC		United States Patent and Trademark Office	11098289	August 24, 2021
	‌ US Patent 8715691 Swine influenza hemagglutinin variants	Patent 8715691 was granted and assigned to MedImmune, LLC on May, 2014 by the United States Patent and Trademark Office.		MedImmune, LLC		United States Patent and Trademark Office	8715691	May 6, 2014
	‌ US Patent 11912782 BCMA monoclonal antibody-drug conjugate	Patent 11912782 was granted and assigned to MedImmune, LLC on February, 2024 by the United States Patent and Trademark Office.	MedImmune, LLC	MedImmune, LLC		United States Patent and Trademark Office	11912782	February 27, 2024
	‌ US Patent 11939382 Bispecific PD-1 and TIGIT binding proteins and uses thereof	Patent 11939382 was granted and assigned to MedImmune, LLC on March, 2024 by the United States Patent and Trademark Office.	MedImmune, LLC	MedImmune, LLC		United States Patent and Trademark Office	11939382	March 26, 2024
	‌ US Patent 11926657 Neutralizing anti-influenza binding molecules and uses thereof	Patent 11926657 was granted and assigned to MedImmune, LLC on March, 2024 by the United States Patent and Trademark Office.	MedImmune, LLC	MedImmune, LLC		United States Patent and Trademark Office	11926657	March 12, 2024
	‌ US Patent RE49908 Bispecific binding proteins and uses thereof	Patent RE49908 was granted and assigned to MedImmune, LLC on April, 2024 by the United States Patent and Trademark Office.	MedImmune, LLC	MedImmune, LLC		United States Patent and Trademark Office	RE49908	April 9, 2024

12 results

0 selected

12 results

0 selected